The Peter Attia Drive cover image

#65 - Rick Doblin, Ph.D.: MDMA— the creation, scheduling, toxicity, therapeutic use, and changing public opinion of what is possibly the single most important synthetic molecule ever created by our species

The Peter Attia Drive

NOTE

The FDA's Rejection of Protocols and the DEA's Role in Rescheduling

During a period when psychedelic research faced strong backlash, the FDA and the courts rejected protocols for rescheduling drugs. The DEA eventually deferred authority to the FDA, who still require phase three studies. However, a recent law now requires the DEA to reschedule within 90 days if the FDA deems a drug medicinal.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner